Company news
Futura Medical plc news in 2024
Futura Medical plc's news releases, calls and decks from 2024, newest first.
TR-1: Notification of major holdings
November 15, 2024
Encouraging New Product Development Pipeline
November 4, 2024
Clinical trial data presented at SMSNA
October 17, 2024
Further milestone payment triggered post US launch
October 7, 2024
Directors’ / PDMR Dealing
September 13, 2024
Trinity Delta research note & consensus forecasts
September 11, 2024
Futura Medical - Interim Results 2024
September 10, 2024
Update on US Launch
September 2, 2024
Notice of Results
August 19, 2024
Update on US launch
August 1, 2024
Nominated Adviser and Joint Broker
July 1, 2024
AGM Statement
June 20, 2024
Block Listing Six Monthly Review
May 31, 2024
Directors’ / PDMR Dealing and Grant of Options
April 29, 2024
Futura Medical targets global expansion with Eroxon, eyeing profitability in 2024
April 11, 2024
Results for the Year ended 31 December 2023
April 10, 2024
Eroxon to be available on prescription
February 14, 2024
Futura Medical marks pivotal year with first meaningful revenue from Eroxon sales
February 8, 2024
Appointment of Joint Corporate Broker
February 6, 2024
Director/PDMR Dealing
January 17, 2024
Futura Medical extends collaboration with Cooper
January 15, 2024
Appointment of Roy Davis as Non-Executive Director
January 9, 2024